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Before the beginning of the pandemic of the 
Coronavirus Disease 2019 (COVID-19), caused, by the 
infection due to the Severe Acute Respiratory Syndrome 
coronavirus 2 (SARS-CoV-2), there was already concern 
in many regions of the world, as occurred in Latin 
America but certainly also in Africa and Asia, regarding 
the epidemiology of communicable diseases in these 
areas, including tropical diseases [1-4]. 
As usually occurs in other epidemics, during the 
pandemic there is high suspicion on COVID-19 
diagnosis, especially when presenting with classical 
associated symptoms; many of them, as happens with 
fever, that may overlap with many other infectious and 
tropical diseases, including dengue, malaria, 
leptospirosis, acute Chagas disease, salmonellosis, 
among many other [5-8].  
But during the COVID-19 pandemic, not everything 
is COVID-19. A lot of usual and endemic conditions 
differential diagnoses should be always considered, but 
even the possibility of coinfections, as these conditions 
may overlap between them, as reported in the past, e.g. 
coinfections of dengue-chikungunya-Zika [9, 10], 
dengue-leptospirosis-chikungunya [11], Zika-HIV [12], 
among other, but now, also with COVID-19 (Figure 1). 
  
Figure 1. Overlapping between COVID-19 and tropical pathogens.  
 
 
Them, from the epidemiological point of view, the 
surveillance should be kept, but even enhanced in most 
critical endemic areas. Additionally, education and 
training about coinfection is key. Clinical findings may 
overlap between COVID-19 and other tropical endemic 
diseases. This should be considered in febrile patients 
who lives in endemic areas or comes from them during 
the last month, according to the suspected pathology (e.g. 
malaria up to 1 month; arboviral diseases, last 14 days) 
[13]. 
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From the diagnostic point of view, is key to 
understand that serological tests may yield cross-
reactions and false-positive results. Then, when 
coinfection is specially suspected, molecular tests are 
preferred, RT-PCR for SARS-CoV-2 infection and for 
other tropical pathogens, as is the case of Dengue. For 
this major arboviral disease, the use of NS1 antigen is 
also recommended for diagnostics even in the context of 
COVID-19. But for other pathogens, gold standard 
diagnostic techniques are also recommended in this 
setting, as is the case of blood thick and thin smear for 
malaria and rapid tests. Similarly with the blood smear 
for Chagas disease (acute). In the case of leptospirosis 
the use of microagglutination test (MAT), ELISA for 
Hantavirus, as well as other serological tests for example 
for tick-borne diseases [13]. 
Among the tropical diseases of interest, probably 
Dengue has been the most studied in relationship with its 
circulation and coinfections with SARS-CoV-2/COVID-
19. Initially during the beginning the pandemic in 2020 
some case reports from French islands, such as Mayotte 
and La Reunión [7, 14], begun to show that Dengue and 
COVID-19 may present with coinfection. This was 
reported and observed initially in travelers, but later, in 
different countries, including in Latin America, 
Argentina, Guadalupe, and Colombia, also in native 
population in endemic areas [15-17]. Nevertheless, the 
first case series, of 13 patients with dengue/COVID-19 
coinfection was published in 2021, from Argentina [18], 
showing that this may occur but not finding critical care 
requirement and evolution to severe forms. Also, another 
13-patients case series from Brazil, recently published, 
showed too similar results without fatal outcomes [19]. 
But recently also, in 2021, in Peru, a study with 50 cases 
was published, finding that patients may evolve to severe 
forms and present fatal outcomes associated with the 
Dengue/SARS-CoV-2 coinfection [20]. In this study the 
overall case fatality rate was 28%, probably influenced 
by their comorbidities (32% hypertension, 26% 
diabetes). Then, the diagnostic and therapeutic aspects 
are challenges for this tropical pathogen, cocirculating 
and coinfecting with SARS-CoV-2/COVID-19. 
As exampled from the situation with dengue, 
similarly may this occur with other tropical pathogens 
(Figure 1), then, this should be promoted and considered 
in the context of COVID-19, as well as also in the context 
of control programs from these tropical diseases, 
including dengue, malaria, Chagas disease, vector-borne 
disease, as well as for zoonotic diseases [21]. Finally, as 
has been clearly stated in multiple areas, COVID-19 is 
affecting the function of multiple control programmes. 
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